Klaus Krainer Jønsson

Klaus Krainer Jønsson, MSc, is Finance Director of Hemab. He has more than 20 years of experience in the finance sector, and he has held finance leadership positions at Y-mAbs Therapeutics, Novo Nordisk, Roche and Nycomed, among others. He received an MSc in Business Economics and Auditing from Copenhagen Business School, Denmark.